Impurity reference standards
Gefitinib impurities & reference standards
Characterised Gefitinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
37reference materials
2isotope-labelled
COAHPLC · NMR · MS on request
2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzamide
- CAS
- 246512-44-7
- Formula
- C15H23N3O4
- MW
- 309.36 g/mol
VQ-043564
2-Amino-4-Methoxy-5-(3-Morpholinopropoxy)benzonitrile
- CAS
- 675126-27-9
- Formula
- C15H21N3O3
- MW
- 291.35 g/mol
VQ-037491
3-(3-Chloro-4-fluorophenyl)-7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl Acetate
- CAS
- 2512211-98-0
- Formula
- C17H12ClFN2O4
- MW
- 362.74 g/mol
VQ-034844
3-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one
- CAS
- 1608115-59-8
- Formula
- C22H23ClFN3O4
- MW
- 447.9 g/mol
VQ-030955
3-Desmorpholinyl-3-hydroxyethylamino Gefitinib
- CAS
- 847949-56-8
- Formula
- C20H22ClFN4O3
- MW
- 420.9 g/mol
VQ-037494
3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate
- CAS
- 179688-53-0
- Formula
- C11H10N2O4
- MW
- 234.21 g/mol
VQ-030954
4-(3-((4-Chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine
- CAS
- 199327-59-8
- Formula
- C16H20ClN3O3
- MW
- 337.8 g/mol
VQ-037492
4-Methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile
- CAS
- 675126-26-8
- Formula
- C15H19N3O5
- MW
- 321.33 g/mol
VQ-030956
Gefitinib 3,4-Difluoro Impurity Hydrochloride
- CAS
- 184475-68-1
- Formula
- C22H25ClF2N4O3
- MW
- 466.9 g/mol
VQ-048508
Methyl 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzoate
- CAS
- 214472-41-0
- Formula
- C16H24N2O5
- MW
- 324.37 g/mol
VQ-044188
Methyl 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzoate
- CAS
- 214472-37-4
- Formula
- C16H22N2O7
- MW
- 354.35 g/mol
VQ-044189
N-(3-Chloro-2-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine
- CAS
- 909863-33-8
- Formula
- C22H24ClFN4O3
- MW
- 446.9 g/mol
VQ-037493
N-(3,4-Dichlorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine
- CAS
- 2089650-13-3
- Formula
- C22H24Cl2N4O3
- MW
- 463.4 g/mol
VQ-048509
N-(4-Fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine
- CAS
- 2254241-82-0
- Formula
- C22H25FN4O3
- MW
- 412.5 g/mol
VQ-043185
FAQs — Gefitinib impurities
Which Gefitinib impurities do you supply?
We list 37 Gefitinib-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Gefitinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Gefitinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Gefitinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.